What question did this study set out to answer?

This research aims to elucidate how N-ethylmaleimide (NEM) treatment affects the relaxation of myosin in actomyosin systems.

November 16, 1976Biochemistry

Mechanism of inhibition of relaxation by N-ethylmaleimide treatment of myosin

View Full Paper

Ask AI

Bookmark

Population

Actomyosin systems from rabbit skeletal muscle

Design

Preclinical

Authors

NEM-myosin may sustain rigor and impair relaxation; leaves open relevance to cardiac thin-filament regulation in vivo.

This research aims to elucidate how N-ethylmaleimide (NEM) treatment affects the relaxation of myosin in actomyosin systems.
Investigated the effects of NEM treatment on heavy meromyosin (HMM) and acto-HMM interactions.
Analyzed the inability of NEM-treated complexes to dissociate in the presence of ATP.
Examined the impact of adding NEM-treated myosin to regulated actomyosin.
NEM treatment resulted in acto-HMM complexes that were not dissociated by ATP, indicating maintained rigor complexes.
NEM-treated myosin inhibited relaxation in native actomyosin systems when mixed.

Population

Actomyosin systems from rabbit skeletal muscle

Intervention

N-ethylmaleimide (NEM) treatment of myosin or heavy meromyosin (HMM)

Outcome

Inhibition of relaxation and dissociation of acto-HMM complexes by ATP

NEM treatment of myosin inhibits relaxation by maintaining rigor complexes with actin even in the presence of ATP.

Pemrick et al. (1976) studied this question.

View Full Paper

Ask AI

Bookmark